Need to improve your skills?
EUPATI Learning Lab is our training portfolio for academia and industry members looking to upskill in the area of patient involvement. Check out our portfolio below and advance your learning today.
Catalysing Change: Participants Perspectives on the EUPATI Learning Lab Trainings
Learning Lab is our training portfolio for academia and industry looking to upskill in patient involvement. We conducted an evaluation report summarising our participants perspectives from 2019-2024.
Check out this report today!
Our portfolio
Explore and choose the right training course for you
-
EUPATI FUNDAMENTALS
Learn the basics of patient involvement
-
EUPATI ESSENTIALS
Take your learning to the next level
-
EUPATI CUSTOMISED
Let us personalise your training
Who
These trainings are designed for those working in
-
Academic research
-
Pharma/MedTech
-
Project Consortia
Benefits
Designed with you in mind
-
Multi-stakeholder design
-
Interactive
-
Solution-based learning
-
Easily accessible
-
Fits your schedule
Our impact
-
![]()
1767+
Professionals Trained
-
![]()
115+
Organisations
What is EUPATI Learning Lab?
Check out out the details of what EUPATI Learning Lab can offer to researchers, individual organisations or project consortia
Our trainers
"Inês Alves is an EUPATI Fellow since 2016, member of the EUPATI Faculty and the vice-president of EUPATI Portugal and member of the Committee for Orphan Medicinal products at the EMA. Founder and president of ANDO Portugal, has been dedicated to advocacy and patient participation and involvement in R&D in skeletal dysplasias since 2014. Currently in a Ph.D. programme in Human Kinetics at Évora University, is a researcher at the Comprehensive Health Research Center- CHRC."
Inês Alves
"Tamás Bereczky has been active in EUPATI since 2014, leading the development of training and content of EUPATI (until April 2020). He holds a PhD in Social Psychology and has extensive expertise in training and educational methods, practical training, and research methodology. Tamás is engaged in both the theory and practice of patient involvement and patient education."
Tamás Bereczky
"Ingrid Klingmann is a physician with a specialisation in general medicine, clinical pharmacology and pharmaceutical medicine. She has 30+ years of experience in developing new treatments from different perspectives in clinical development strategy, methodology and operations, ethical aspects, regulatory affairs and quality standards like Good Clinical Practice. A patient herself, she has also been working for 20 years on patient involvement through various infrastructures."
Ingrid Klingmann
"Jana Popova is the EUPATI Patient Engagement Training Coordinator and has been active as a patient advocate since 2006, coming from the rare diseases field. She also has a PhD in media and digital communications and has extensive experience in patient engagement and training methods."
Jana Popova
"Anke-Peggy is the founder of Health Outcomes Strategies GmbH (www.health-os.com). Her expertise is the value of healthcare products and policy decisions related to healthcare products, reimbursement strategies, outcomes research and health economics, health technology assessment processes, payer interactions, product / device / service synergies, and the patient perspective."
Anke-Peggy Holtorf
"Karen Facey is an independent consultant on matters related to HTA. In 2017 Karen established a new HTA body in Wales with innovative patient involvement processes and led publication of the book on Patient Involvement in HTA.She sits on the non- medicines HTA committee in Scotland and has a particular interest in the appraisal of rare disease treatments. She founded the HTA International Interest Group for Patient and Citizen Involvement."
Karen Facey
"Paola has a background in EU Public Affairs and after being diagnosed with a neurological chronic disease she has turned her attention to Patient Advocacy and she has participated in the European project EUPATI (European Patients’ Academy on Therapeutic Innovation). She is listed among EMA’s Patient Experts and she has been member of an Ethics Committee for two years.
Patient reviewer for different scientific journals and author of several publications on the issue of patient engagement, she represents patients in many boards and Scientific Committees.
Her main area of interest is how to engage patients in clinical research, as she believes that good research needs to involve patients from the beginning and incorporate their voice."
Paola Kruger
"
Mandy is a EUPATI Fellow, the founder of the Irish Neonatal Health Alliance and has been a patient advocate for 20 years, working across all aspects of medicines development from concept to post marketing authorisation. Additionally she has experience working in the research ethics, clinical research, clinical audit and education fields.
"
Mandy Daly
"Beate Rohde is a physician with specialisation in clinical pharmacology / pharmaceutical medicine. She joined the EUPATI learning lab faculty in 2024 after more than 25 years experience working in pharmaceutical industry. There her main focus was on leading teams of scientist in early phases of clinical development of new treatments addressing unmet medical needs in several indication areas. Her tasks included the scientific, methodological, regulatory as well as operational aspects. During her career she also acquired growing insights into engagement of patients into pharmaceutical development."
Beate Rohde
"Carolyn Ingram is a public health researcher and educator with expertise in health technology assessment and public health policy. She holds a Master’s degree in Global Health from the University of Bordeaux and is currently finishing her PhD in Public Health Research from University College Dublin (UCD), focusing on community health needs in vulnerable populations. As an Education Technologist at UCD, Carolyn designs and delivers course content on evidence synthesis and comparative effectiveness research. She joined EUPATI as a consultant and trainer in 2023 and has helped develop educational materials aimed at making the new EU Health Technology Assessment Regulation understandable and accessible to patients and professionals."
Carolyn Ingram
